Nature Reviews Immunology 2, 725–734 (2002)
On page 728 of this article, the following incorrect sentence was published:
'The complex of transforming-growth-factor-β-activated kinase 1 (TAK1), TAK1-binding protein 1 (TAB1) and TAB2 was thought to be an integral component that relays the signals to IKK complexes downstream of TRAF6 (REF. 20), but recent results from TAK1- and TAB2-knockout mice do not support a role for these proteins in NF-κB signalling (S. Akira, personal communication).'
However, the phenotype of TAK1-knockout mice is under investigation at present. Therefore, the suggestion that TAK1 does not have a role in tumour-necrosis-factor–interleukin-1 signalling remains to be substantiated.
Additional information
The online version of the original article can be found at 10.1038/nri910
Rights and permissions
About this article
Cite this article
Li, Q., Verma, I. Erratum: NF-κB regulation in the immune system. Nat Rev Immunol 2, 975 (2002). https://doi.org/10.1038/nri968
Issue Date:
DOI: https://doi.org/10.1038/nri968
This article is cited by
-
The Toxoplasma gondii ME-49 strain upregulates levels of A20 that inhibit NF-κB activation and promotes apoptosis in human leukaemia T-cell lines
Parasites & Vectors (2018)
-
Revealing the immune perturbation of black phosphorus nanomaterials to macrophages by understanding the protein corona
Nature Communications (2018)
-
Regulation of IκBα expression involves both NF-κB and the MAP kinase signaling pathways
Journal of Inflammation (2005)
